Research programme: gastroenterology therapies - TAP PharmaceuticalAlternative Names: Acid-related disease therapies - TAP Pharmaceutical Products; Gastroenterology therapies research programme - TAP Pharmaceutical Products
Latest Information Update: 13 Feb 2008
At a glance
- Originator TAP Pharmaceutical Products
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 13 Feb 2008 No development reported - Preclinical for Gastrointestinal disorders in USA (unspecified route)
- 30 Aug 2005 Preclinical trials in Gastrointestinal disorders in USA (unspecified route)